Startups like Elon Musk’s Neuralink, Precision Neuroscience and Synchron are developing brain-computer interfaces to make them more accessible and less invasive. Christopher Mims, tech journalist at The Wall Street Journal, explains the ethical, technical and regulatory challenges these startups are facing.